We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

373 hedge funds and large institutions have $9.87B invested in Jazz Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 121 increasing their positions, 146 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 30

9% more capital invested

Capital invested by funds: $9.08B → $9.87B (+$788M)

5% more funds holding

Funds holding: 354 → 373 (+19)

17% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 146

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

52% less call options, than puts

Call options by funds: $54M | Put options by funds: $113M

Holders
373
Holders Change
+19
Holders Change %
+5.37%
% of All Funds
10.05%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
51
Increased
121
Reduced
146
Closed
30
Calls
$54M
Puts
$113M
Net Calls
-$59.1M
Net Calls Change
-$28.4M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$272M
2
BIT
BlackRock Institutional Trust
California
+$261M
3
PC
PointState Capital
New York
+$76.6M
4
BG
BlackRock Group
United Kingdom
+$71.1M
5
NC
Nicholas Company
Wisconsin
+$60.4M

Top Sellers

1
Wells Fargo
Wells Fargo
California
-$68.1M
2
JHIU
Janus Henderson Investors US
Colorado
-$65.5M
3
HM
HealthCor Management
New York
-$56.2M
4
LPC
Lone Pine Capital
Connecticut
-$45.1M
5
Franklin Resources
Franklin Resources
California
-$27.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
26
Nicholas Company
Wisconsin
$67.9M +$60.4M +336,280 +684%
American Century Companies
27
American Century Companies
Missouri
$64.3M +$893K +4,973 +1%
Morgan Stanley
28
Morgan Stanley
New York
$63.5M -$7.98M -44,433 -11%
Norges Bank
29
Norges Bank
Norway
$63.2M – – –
Geode Capital Management
30
Geode Capital Management
Massachusetts
$62.1M +$2.17M +12,080 +4%
AAMU
31
Amundi Asset Management US
Massachusetts
$56.8M -$109K -608 -0.2%
ACM
32
Apex Capital Management
Ohio
$51.7M +$2.56M +14,248 +5%
TA
33
Teachers Advisors
New York
$50.2M +$192K +1,069 +0.4%
Deutsche Bank
34
Deutsche Bank
Germany
$44.3M +$11M +61,131 +32%
CCI
35
Columbus Circle Investors
$40.3M -$10.4M -58,160 -20%
BA
36
BlackRock Advisors
Delaware
$40.3M +$41.1M +228,778 New
First Trust Advisors
37
First Trust Advisors
Illinois
$37.9M +$6.66M +37,098 +21%
RIM
38
RS Investment Management
California
$37.4M -$6.88M -38,281 -15%
AAP
39
Ardsley Advisory Partners
Connecticut
$37.3M -$4.06M -22,600 -10%
Bank of America
40
Bank of America
North Carolina
$35.5M +$302K +1,679 +0.8%
BGIM
41
Brandywine Global Investment Management
Pennsylvania
$34.2M +$2.07M +11,550 +6%
Zurich Cantonal Bank
42
Zurich Cantonal Bank
Switzerland
$33.4M -$1.75M -9,727 -5%
Ninety One (UK)
43
Ninety One (UK)
United Kingdom
$32.4M -$2.82M -15,699 -8%
Citadel Advisors
44
Citadel Advisors
Florida
$31.9M +$2.11M +11,755 +7%
CCM
45
Cadian Capital Management
New York
$30.8M +$11.7M +65,000 +59%
CM
46
Churchill Management
California
$30.2M -$3.69M -20,548 -11%
CS
47
Credit Suisse
Switzerland
$30M -$4.61M -25,692 -13%
KI
48
Kalmar Investments
Delaware
$28M -$104K -580 -0.4%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$27.5M -$1.21M -6,755 -4%
UBS Group
50
UBS Group
Switzerland
$27.2M +$5.53M +30,766 +25%
1
2
3 4 5

JAZZ Hedge Fund Activity: Q2 2015 in Review

373 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2015, worth a combined $9.87B — up 8.7% from $9.08B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new JAZZ positions and 30 closed out — a net gain of 21 holders — while 121 added to existing stakes and 146 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $272M. The largest seller was Wells Fargo, cutting an estimated $68.1M.

  • 373 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2015, up from 354 in Q1 2015.
  • Funds reported $9.87B of Jazz Pharmaceuticals stock for Q2 2015, up 8.7% quarter-over-quarter.
  • 51 funds opened new Jazz Pharmaceuticals positions in Q2 2015 and 30 closed out, a net change of +21 holders.
  • The largest Jazz Pharmaceuticals buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $272M added.
  • The largest Jazz Pharmaceuticals seller in Q2 2015 was Wells Fargo, an estimated $68.1M sold.

Based on aggregated 13F filings for Q2 2015.